Start-Up Previews (10/03)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, RNAi-Based Drug Development Strategies, features profiles of Acuity Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc. and Nucleonics Inc. Plus these Start-Ups across Health Care: Afferent Corp., Anacor Pharmaceuticals Inc., Kemia Inc. and ParAllele BioScience Inc.
You may also be interested in...
Confidence in the vaccine has slipped in the US, regardless of political affiliation.
Janssen presents highly encouraging interim results at ESMO from the CHRYSALIS study with a combination of amivantamab and lazertinib. Based on the data, the global Phase III MARIPOSA study, which will assess the combo versus blockbuster Tagrisso, will begin next month including in South Korea, home to lazertinib's originator.
Frank Zhang, co-founder and chair of the Hong Kong-listed Chinese biotech Genscript, parent of Nasdaq-listed cell therapy star, Legend Biotech, has been detained by Chinese authorities, along with four employees.